Table 5 Modifications in target genes of the QRDR, efflux pump regulators, the oprD gene and antimicrobial susceptibility to fluoroquinolones and carbapenems in exoU+ and exoU− isolates.

From: High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant “high-risk clones” of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals

exoU Genotype

Isolates

gyrA

parC

nalD

nalC

mexR

nfxB

mexZ

mexS

mexT

FQ MIC (mg/L)

oprD

IMI

MER

LVX

OFX

CIP

exoU+

1069

G71E

NA-c

0.5

2

0.5

2

S

S

exoU+

1070

T83I

S87L

nt397-398

G71E,S209R

V126E

L105R

64

128

32

W65* + 2

R

R

exoU+

1071

T83I

S87L

G71E,S209R

V126E

L105R

64

128

32

W65* + 2

R

R

exoU+

1072

T83I

S87L

NA

G71E,S209R

V126E,L131P

L105R

NA-b

64

128

64

NA

R

R

exoU+

1073

E153K

R44P

G71E,S209R,A145V

V126E

L105R,R167S

32

64

8

3

S

S

exoU+

1074

G71E,S209R

V126E

NA

NA-c

1

2

0.5

3

S

S

exoU+

1075

T83I

S87L

G71E,S209R,D79E

V126E

G56S

V73A

16

64

16

3

R

R

exoU+

1076

S87L

G71E,S209R

128

>256

128

T103S,K115T,F170L, E185Q,P186G,V189T,G307D

R

R

exoU+

1077

T83I

S87L

G71E,S209R

V126E

64

32

64

insnt 1201-1205 (GTCCA) + 3

R

R

exoU+

1078

T83I

S87L

nt 263-279

V126E

128

256

64

insnt 1201-1205 (GTCCA) + 3

R

R

exoU+

1079

T83I/D87N

S87L

nt 263-279

G71E,S209R

V126E

256

256

256

3

S

S

exoU+

1080

T83I

S87L

nt 263-279

G71E,S209R

V126E

NA-b

-

64

128

64

insnt 1201-1205 (GTCCA) + 3

R

R

exoU+

1081

T83I

S87L

L194R

G71E,S209R

V126E

64

256

64

3

S

S

exoU−

1082

G71E,S209R

NA

0.5

1

0.5

4

S

S

exoU−

1084

T83I

S87L

NA

G71E,A145V,S209R

NA-c

P185R

128

256

64

insnt941–942(GC)

R

R

exoU−

1085

T83I

S87L

nt451-461

G71E,S209R

Y18C

NA-c

128

256

128

S

S

exoU−

1086

T83I

S87L

nt 397-398

G71E,S209R

V126E

AA F103-V112

64

128

64

insnt678 (G) + C

R

R

exoU−

1087

NA

V126E

L105R

NA-c

1

2

0.25

3

R

S

exoU−

1088

NA

V126E

NA-c

NA

0.5

1

0.5

2

S

S

exoU−

1089

T83I

S87L

nt 397-398

G71E,S209R

V126E

L105R

128

128

32

2

R

R

exoU−

1092

D87N

S87L

1

G71E,S209R

V126E

S66L

4

4

2

NA

S

S

exoU−

1093

T83I

nt 397-398

G71E,S209R

V126E

L105R

64

256

32

NA

R

R

exoU−

1094

nt234-243 + G71E,Q81P

NA-b

4

16

0.5

2

S

S

exoU−

1095

T83I

S87L

G71E,S209R

NA

H18Y

NA-b

64

64

32

Y49* + 4

R

R

exoU−

1096

T83I

S87L

nt 391

G71E,S209R

V126E

V72L

G224S

128

128

64

V127L

S

S

exoU-

1097

nt 391

G71E,S209R

NA-b

4

2

0.25

3

S

S

exoU−

1098

T188A

G71E,S209R,P210L

Q21*

1

1

1

insnt 605-609 (CAACA) + 4

R

S

exoU−

1100

T83I

S87L

G71E,S209R

NA

H18Y

64

128

32

Y49* + 4

R

R

exoU−

1102

T83I

S87L

G71E,S209R

V126E

H18Y

16

64

8

Y49* + 4

R

R

exoU−

1103

G71E,A186T

E124K

2

2

0.25

NA

S

S

exoU−

1104

G71E,S209R

L131P

NA-c

8

32

32

4

R

R

exoU−

1105

T83I

S87L

nt 397-398

G71E,S209R

V126E

L105R

64

64

32

W65* + 2

R

R

exoU−

1106

S87L

NA

nt408-409

NA-c

4

2

1

S

S

exoU−

1107

G71E,S209R,P210L

NA

L95M

NA-c

D290E

2

2

0.5

4

S

S

exoU−

1108

T188A

G71E,S209R

0.5

2

0.5

3

S

S

exoU−

1109

G71E,S209R,D79E

NA

0.5

1

0.5

4

S

S

exoU−

1110

T83I

S87L

G71E,S209R

P185R

128

256

128

insnt941–942(GC)

R

S

exoU−

1111

T83I

S87L

NA

H18Y

NA-b

128

 > 256

128

Y49* + 4

R

R

exoU−

1112

T83I

S87L

G71E,S209R

NA

H18Y

NA-b

64

128

64

Y49* + 4

R

R

exoU−

1113

T83I

S87L

nt 397-398

G71E,S209R

V126E

L105R

128

128

32

W65* + 2

R

R

exoU−

1114

S87L

G71E,S209R

16

32

16

4

S

S

exoU−

1115

T83I

S87L

G71E,S209R

32

64

32

4

S

S

exoU−

1116

T83I

S87L

G71E,S209R

32

64

32

4

S

S

exoU−

1117

NA-c

16

4

0.25

4

S

S

exoU−

1118

T83I/D87N

S87L

nt 263-279

G71E,S209R

V126E

128

>256

>256

3

S

S

exoU−

1119

T83I

S209R

V126E

NA-b

8

16

4

4

S

S

exoU−

1120

G71E,S209R

V126E

NA-d

8

4

2

4

S

S

exoU−

1121

G71E,S209R

NA

L141Q

NA-c

8

64

1

insnt1087(A) + ∆nt 1294(T) + T103S,K115T,F170L

R

R

exoU−

1122

D87N

G71E,S209R

NA-c

64

64

64

Y49* + 4

R

R

exoU−

1123

T83I

S87L

G71E,S209R

NA

H18Y

64

128

32

Y49* + 4

R

R

  1. The symbol “−” represent wild type isolates; NA: No amplification; the symbol ∆nt represents nucleotide deletion being noted the first and last nucleotides deleted; the symbol ∆AA represents amino acid deletions being noted the first and last amino acid deleted; insnt: nucleotide insertion; The symbol “*” represents codon STOP. FQ-MIC: MIC to fluoroquinolones (LVX: Levofloxacin; OFX: Ofloxacin; CIP: Ciprofloxacin); IMI/MER are isolates showing susceptibility (S); resistance or intermediate susceptibility (R) to imipenem or meropenem performed by the disk diffusion assay.
  2. Alterations at nalC, nalD, mexR, mexS and mexT as well as the patterns of OprD were previously described17. The patterns of OprD are named accordingly to Horna et al.17.
  3. 1. Amino acid substitutions: Q134H, Q142H, A145P, D147H, E148K, C149R, H154P, R160K, D176E, D185Y, G206S, S209I.
  4. 2. oprD-Pattern C17: V127L, E185Q, P186G, V189T, E202Q, I210A, E230K, S240T, N262T, T276A, A281G, K296Q, Q301E, R310E, (±G312R), A315G, L347M, S403A, Q424E + 372V-DSSSSYAGL-383.
  5. 3. oprD-Pattern B17: T103S, K115T, F170L, E185Q, P186G, V189T, R310E, A315G, (±G425A).
  6. 4. oprD-Pattern A17: E202Q, I210A, E230K, S240T, N262T, A267S, A281G, K296Q, Q301E, R310G, (±V352I), V359L, (±Q424R) + 372V-DSSSSYAGL-383.
  7. NA-b: No amplification of mexS gene but amplification of N- and C-terminal regions.
  8. NA-c: No amplification of mexS gene but amplification of N-terminal region.
  9. NA-d: No amplification of mexS gene and no amplification of N- and C- terminal regions.